A high DHEA result usually reflects an adrenal hormone signal, a supplement effect, or less often an ovarian or adrenal disorder. The exact assay, unit, symptoms, speed of change, and companion hormones determine whether it needs a routine repeat or prompt endocrine review.
Tämä opas on kirjoitettu Tohtori Thomas Klein, lääketieteen tohtori yhteistyössä Kantestin tekoälyn lääketieteellinen neuvoa-antava toimikunta, mukaan lukien professori Hans Weberin osuudet ja tohtori Sarah Mitchellin, MD, PhD, tekemä lääketieteellinen katsaus.
Thomas Klein, lääketieteen tohtori
Ylilääkäri, Kantesti AI
Tohtori Thomas Klein on hallituksen sertifioima kliininen hematologi ja sisätautilääkäri, jolla on yli 15 vuoden kokemus laboratoriolääketieteestä ja tekoälyavusteisesta kliinisestä analyysistä. Lääketieteellisenä johtajana (Chief Medical Officer) Kantesti AI:ssa hän valvoo omistusoikeudellisen hermoverkon lääketieteellistä tarkkuutta. Tohtori Klein on julkaissut tutkimuksia biomarkkereiden tulkinnasta ja laboratoriodiagnostiikasta.
Sarah Mitchell, lääketieteen tohtori
Lääketieteellinen pääneuvonantaja - kliininen patologia ja sisätaudit
Tohtori Sarah Mitchell on hallituksen sertifioima kliininen patologi, jolla on yli 18 vuoden kokemus laboratoriolääketieteestä ja diagnostisesta analyysistä. Hänellä on erikoistason sertifikaatit kliinisen kemian alalta, ja hän on julkaissut laajasti biomarkkeripaneeleista ja laboratoriotutkimusten analyysistä kliinisessä käytännössä.
Professori, tohtori Hans Weber, filosofian tohtori
Laboratoriolääketieteen ja kliinisen biokemian professori
Prof. Dr. Hans Weber tuo mukanaan 30+ vuoden asiantuntemuksen kliinisestä biokemiasta, laboratoriolääketieteestä ja biomarkkeritutkimuksesta. Hän oli aiemmin Saksan kliinisen kemian seuran (German Society for Clinical Chemistry) presidentti, ja hän erikoistuu diagnostisten paneelien analyysiin, biomarkkereiden standardointiin sekä tekoälyavusteiseen laboratoriolääketieteeseen.
- DHEA-S source: DHEA-S is produced almost entirely by the adrenal glands, while DHEA can come from adrenal, ovarian, and peripheral tissues.
- Lab ranges vary: Many laboratories list a DHEA-S upper limit around 320-430 µg/dL for women aged 18-29, with lower upper limits after age 30.
- Tumour threshold: DHEA-S above 700 µg/dL warrants prompt assessment for an adrenal source, particularly with rapid virilisation.
- PCOS-malli: PCOS may cause mild-to-moderate androgen elevation, but a very high DHEA-S result is not typical and should not be attributed to PCOS automatically.
- Key screening test: An early-morning follicular-phase 17-hydroxyprogesterone above 200 ng/dL commonly prompts ACTH stimulation testing for non-classic congenital adrenal hyperplasia.
- Medication check: DHEA supplements, testosterone exposure, danazol, some anti-seizure medicines, and assay interference can alter androgen results.
- Kiireelliset oireet: New deepening of the voice, rapidly progressive facial hair, scalp hair loss, increasing muscle mass, or clitoral enlargement need timely medical review.
- Retest method: LC-MS/MS is generally preferred for low female androgen concentrations when an immunoassay result does not fit the clinical picture.
What a High DHEA Result Means in Women
High DHEA causes in women most often involve adrenal hormone production, a DHEA-containing supplement, or an assay and timing issue; the result alone does not diagnose PCOS or a tumour. As of August 24, 2026, the practical first step is to confirm whether the report measured DHEA or DHEA-S, then place the number beside testosterone, menstrual history, and the pace of any physical changes.
A flagged result can be unsettling, but the flag only means the value lies outside that laboratory's reference interval. DHEA-S yli 700 µg/dL is a useful prompt for expedited adrenal evaluation in an adult woman, whereas a small isolated rise just above a laboratory upper limit often has a much less dramatic explanation. Read the actual range, assay method, and unit before drawing conclusions; our guide to poikkeavien laboratoriolippujen explains why this matters.
DHEA is a weak androgen and precursor for testosterone and oestrogens. Its concentration changes more over a day than DHEA-S because DHEA has a short circulating half-life, roughly 15-30 minutes; DHEA-S lasts about 7-10 hours and is therefore the steadier adrenal marker. Kantesti is an AI blood test analyzer that reads the reported analyte, unit, age-specific range, and related hormones rather than treating every high flag as equivalent.
In my clinical work, the most useful question is not "how high is it?" but "high compared with what pattern?" A 24-year-old with irregular cycles, modestly raised testosterone, and DHEA-S of 410 µg/dL needs a different discussion from a 48-year-old whose DHEA-S has newly reached 920 µg/dL with voice change. Dr. Thomas Klein would review these as distinct clinical problems, not different points on the same scale.
The first details to copy from your report
Record the exact test name, result, unit, laboratory range, collection time, cycle day, pregnancy status, medicines, and supplements. These seven details can prevent a needless scan or, conversely, stop a serious androgen-excess pattern from being dismissed.
DHEA vs DHEA-S: Why the Difference Changes the Work-Up
DHEA-S is predominantly an adrenal hormone, while DHEA is less source-specific and fluctuates more. A high DHEA-S in women therefore points more strongly toward adrenal production than an isolated high DHEA result does.
DHEA is dehydroepiandrosterone; DHEA-S is its sulfated storage form. The added sulfate group makes DHEA-S more abundant and stable in circulation, so endocrinologists commonly choose it when trying to establish whether androgen excess has an adrenal contribution. For a closer explanation of source and timing, compare DHEA-S:ää ja DHEA:ta.
There is no single universal female DHEA-S range. A typical upper limit may be 430 µg/dL at ages 18-29, 320 µg/dL at ages 30-39ja 220 µg/dL at ages 40-49, but local methods differ materially; some European laboratories report in µmol/L, where 1 µg/dL is approximately 0.027 µmol/L. Age-adjustment matters because adrenal androgen output falls steadily after the third decade.
An isolated serum DHEA value can be higher after an early-morning draw, acute illness, intense exercise, or recent ingestion of a supplement. DHEA-S is not immune to variation, but a repeat result is usually easier to interpret. A test labelled simply "DHEA" should never be used as a substitute for DHEA-S without checking what the clinician was trying to answer.
Adrenal Causes of Elevated DHEA-S in Women
Adrenal causes of high DHEA-S include physiologic variation, non-classic congenital adrenal hyperplasia, ACTH-driven adrenal stimulation, and rarely an androgen-producing adrenal growth. A DHEA-S result above 700 µg/dL or rapidly rising values deserve prompt clinician review, especially when virilisation is present.
Non-classic 21-hydroxylase deficiency can present after puberty with acne, hirsutism, irregular periods, or difficulty conceiving. A follicular-phase sample collected around 8 a.m. with 17-hydroxyprogesterone above 200 ng/dL (about 6 nmol/L) usually leads to an ACTH stimulation test; a stimulated value above roughly 1,000 ng/dL strongly supports the diagnosis. The Endocrine Society guideline led by Speiser et al. (2018) recommends early-morning screening and confirmatory testing rather than diagnosing this condition from DHEA-S alone.
ACTH is the pituitary signal that can stimulate adrenal androgen output. In ACTH-dependent cortisol excess, DHEA-S may be normal or elevated; in cortisol-producing adrenal disease that suppresses ACTH, DHEA-S may instead be low. This contrast is why a cortisol result without reliable ACTH collection details can mislead even experienced clinicians.
Adrenal androgen-producing tumours are uncommon, but their pattern is distinctive: DHEA-S is often markedly elevated, symptoms advance over months rather than years, and testosterone may be high too. Imaging is generally considered after biochemical confirmation, not as a first response to a borderline result. A single high value after DHEA supplementation is not evidence of an adrenal mass.
Why cortisol belongs in the same conversation
Cortisol and DHEA arise from neighbouring adrenal pathways but do not move together reliably. A properly timed cortisol assessment can clarify whether ACTH stimulation, suppression, or an unrelated supplement effect is the more plausible explanation; see our practical cortisol and DHEA pattern guide.
Ovarian Causes, PCOS and the Limits of a Single Hormone Test
PCOS is the commonest cause of persistent androgen-excess symptoms in reproductive-age women, but it more often raises testosterone or androstenedione than causes a striking DHEA-S elevation. DHEA-S can be mildly high in PCOS, yet a result near or above 700 µg/dL should trigger a search beyond PCOS.
PCOS is diagnosed from a combination of ovulatory dysfunction, clinical or biochemical hyperandrogenism, and ovarian morphology when other causes have been excluded. The Androgen Excess and PCOS Society statement by Azziz et al. (2009) describes PCOS as predominantly hyperandrogenic, but no DHEA-S number independently confirms it. Acne plus irregular periods and a high DHEA-S is suggestive, not diagnostic.
Ovarian androgen-producing growths usually produce testosterone concentrations above 150-200 ng/dL and more rapid virilisation than ordinary PCOS. DHEA-S is often normal in a purely ovarian source, which is a useful clue but not a perfect rule. For cycle-aware testing after contraception, our article on PCOS tests after birth control covers the waiting period and its limits.
Kantesti is an AI blood test interpretation platform that places DHEA-S alongside total testosterone, SHBG, LH, FSH, prolactin, glucose, and HbA1c when those values are available. That context matters because insulin resistance can amplify ovarian androgen production, while it does not explain every adrenal-range DHEA-S result. The broader naisten hormoniterveyden oppaassamme is useful before assuming one diagnosis.
A common misconception about ovarian cysts
The polycystic appearance on ultrasound does not mean individual cysts are secreting DHEA. PCOS is a metabolic-endocrine syndrome, and many women with it have normal ultrasound findings while others with polycystic morphology do not have PCOS.
Medication, Supplement and Assay Reasons for High DHEA
DHEA capsules are the most straightforward reversible cause of high DHEA or DHEA-S, and even 25-50 mg daily can push a result beyond a laboratory range. Medication review should occur before endocrine imaging, but prescribed medicines should not be stopped without the prescriber's advice.
DHEA is sold in some countries as an over-the-counter supplement and may appear in products marketed for energy, libido, menopause, or "adrenal support." Contamination or incomplete labelling is possible in mixed hormonal products. Testosterone gels used by a partner can also transfer through close skin contact, raising female androgen levels despite no intentional prescription.
Danazol, valproate, some progestins, and glucocorticoid changes can alter the wider androgen picture, though they do not all directly raise DHEA-S. Combined oral contraceptives commonly lower DHEA-S and free testosterone, so a normal value while taking one does not rule out baseline androgen excess. Read more about DHEA-S on birth control.
Immunoassays are vulnerable at the low concentrations typical in women, and biotin can distort selected streptavidin-biotin assays. LC-MS/MS provides better analytic specificity for total testosterone and is useful when a result clashes with the history; DHEA-S methods also vary between laboratories. Hold biotin for at least 48 hours before a planned draw if your laboratory advises it, and disclose it either way.
Mitä ottaa mukaan vastaanotolle
Bring photographs of every supplement label, including powders, creams, pellets, and herbal blends, plus the dose and last-use date. In practice, this resolves more confusing panels than patients expect.
High DHEA Symptoms: What You May Notice and What You May Not
High DHEA symptoms are symptoms of androgen excess, not a reliable measure of the number itself. Acne, increased terminal hair on the face or body, scalp hair thinning, irregular periods, and reduced fertility can occur, while many women with a mild DHEA-S rise feel entirely well.
Hirsutism means coarse terminal hair in androgen-sensitive areas, not ordinary fine body hair. The modified Ferriman-Gallwey score uses nine body sites, and a score of 8 or more is often considered abnormal in many populations, although ethnicity and grooming practices change its usefulness. The Endocrine Society hirsutism guideline by Martin et al. (2018) recommends targeted androgen testing when the score is abnormal or symptoms progress.
Rapid changes carry more weight than severity alone. New shaving twice daily, temporal scalp recession, voice deepening, increased muscularity, or clitoral enlargement over 3–12 kuukauden is more concerning for substantial androgen excess than long-standing mild chin hair since adolescence. A useful related overview is our guide to testosteronipitoisuuksista naisilla.
Acne, fatigue, anxiety, low mood, and poor sleep are nonspecific. I would not label them "adrenal fatigue" from a DHEA result; that phrase has no accepted diagnostic test. Dr. Thomas Klein has seen patients feel relieved when this distinction is made, because it redirects attention toward evidence-based causes such as PCOS, thyroid disease, iron deficiency, medication effects, or ordinary life stress.
Symptoms that do not match the number
Hair follicles respond differently to the same androgen concentration because local enzyme activity and genetic sensitivity vary. A woman can have marked hirsutism with normal serum androgens, while another with DHEA-S of 500 µg/dL has few visible changes.
When High DHEA Needs Prompt Clinical Evaluation
Seek prompt medical assessment for high DHEA or DHEA-S with rapid virilisation, DHEA-S above 700 µg/dL, testosterone above about 150-200 ng/dL, or new severe hypertension and cortisol-related symptoms. Most mild elevations are not emergencies, but these combinations should not wait for an annual review.
Virilisation means development of more masculinising features, especially voice deepening, clitoral enlargement, rapidly advancing male-pattern scalp loss, or substantial muscle change. These signs suggest androgen exposure above the level seen in usual PCOS and justify an urgent primary-care, gynaecology, or endocrinology pathway. Rapid onset over a few months is clinically more informative than a long history of stable hair growth.
Call urgent services for severe headache with visual disturbance, chest pain, fainting, confusion, or very high blood pressure; those symptoms are not caused by DHEA alone but may signal a separate endocrine or cardiovascular problem. If weight gain around the trunk, easy bruising, proximal muscle weakness, and new diabetes accompany the result, clinicians may evaluate cortisol excess. Our page on korkeasta kortisolista explains why no single cortisol draw diagnoses Cushing syndrome.
Pregnancy changes the threshold for contact. New androgenic symptoms in pregnancy, particularly rapidly advancing ones, should be discussed promptly with the obstetric team because maternal and fetal contexts differ. Do not begin anti-androgen medicines or DHEA-lowering supplements on your own; several options are unsuitable in pregnancy or without reliable contraception.
What is usually safe to do today
Write down when symptoms began, preserve the laboratory report, and pause non-prescribed DHEA until you have spoken with a clinician. Stopping a supplement is different from stopping prescribed steroid medicine, which can be dangerous abruptly.
How to Repeat DHEA Testing for a More Trustworthy Answer
A repeat DHEA-S test is most useful when collected in the morning, at the same laboratory if possible, after stopping non-prescribed DHEA and documenting cycle timing. DHEA itself is more timing-sensitive than DHEA-S, so an isolated unexpected DHEA result deserves particular caution.
For a reproductive-age woman who menstruates, clinicians often draw androgen tests in the early follicular phase, commonly days 3-5, when practical. This is not mandatory for DHEA-S, but it makes accompanying testosterone, 17-hydroxyprogesterone, LH, FSH, and estradiol easier to compare. Avoid testing during acute febrile illness when the question is a mild unexplained deviation.
Record recent heavy exercise, poor sleep, shift work, alcohol intake, and supplements. These factors rarely explain a DHEA-S of 900 µg/dL, but they can turn a borderline result into noise. If results differ substantially between visits, use the actual dates and collection conditions; our verikokeiden aikajanaopas shows why apparent changes are sometimes pre-analytic rather than biological.
Do not fast solely for DHEA-S unless other ordered tests require it. Fasting is more relevant for glucose, insulin, and lipids than for this adrenal androgen. If testing is part of an infertility evaluation, ask the laboratory or fertility team for their protocol rather than assuming internet advice applies to your medication plan.
Why repeating at another laboratory can confuse matters
A new laboratory may use a different calibration and reference interval, so a result can appear to change even when physiology has not. Repeat at the same site first when confirming a mild abnormality, then use a specialist assay if the clinical picture remains discordant.
Tests Clinicians Use After Elevated DHEA in Women
The next tests after elevated DHEA depend on the level and symptoms, but commonly include DHEA-S, total testosterone by LC-MS/MS, SHBG, 17-hydroxyprogesterone, prolactin, TSH, and pregnancy testing when relevant. Imaging is reserved for a confirmed severe biochemical or virilisation pattern, not routine mild elevation.
Total testosterone and SHBG allow an estimate of free androgen exposure, while DHEA-S helps localise the likely source. Early-morning 17-hydroxyprogesterone screens for non-classic congenital adrenal hyperplasia; prolactin and TSH investigate common reasons for irregular periods that do not themselves explain a high DHEA-S. Our hormonipaneelin tulkintaopas maps these tests to the questions they answer.
If cortisol excess is plausible, the Endocrine Society approach uses validated screening such as late-night salivary cortisol, 24-hour urinary free cortisol, or an overnight 1-mg dexamethasone suppression test rather than a random serum cortisol. A random 9 a.m. cortisol can be useful in selected settings but is not a Cushing screen. The reason is biologic rhythm, not clinician fussiness.
Pelvic ultrasound may help assess ovarian morphology but cannot exclude every small androgen-producing ovarian source. Adrenal CT or MRI is usually targeted when DHEA-S is markedly high or repeat testing confirms a concerning pattern. The question is not whether a scan can find something; it is whether the pre-test probability is high enough for the finding to be meaningful.
Testing for insulin resistance without over-testing
HbA1c, fasting glucose, lipids, blood pressure, and waist measures often matter more for long-term PCOS risk than a fasting insulin result alone. A high fasting insulin can support insulin resistance, but there is no internationally standardised diagnostic cutoff for every laboratory.
How Doctors Read DHEA, Testosterone, Cortisol and ACTH Together
A high DHEA-S with normal testosterone often favours an adrenal contribution, while markedly high testosterone with normal DHEA-S can favour an ovarian source. These are directional clues, not hard diagnostic laws, because hormones overlap and assays have limits.
DHEA-S reflects adrenal zona reticularis activity more directly than testosterone does. Testosterone may be normal when DHEA-S is mildly raised because peripheral conversion differs between individuals. Conversely, a high free testosterone with normal total testosterone can occur when SHBG is low in obesity, hypothyroidism, insulin resistance, or androgen exposure.
Low ACTH plus high cortisol and low DHEA-S suggests ACTH suppression, whereas high ACTH may coexist with higher adrenal androgens in some ACTH-driven states. This is one reason an ACTH sample needs careful handling and interpretation. Kantesti's neural network is an AI-powered blood test analysis tool that compares this multi-analyte pattern with the laboratory's stated intervals, but it cannot replace a clinician's examination or confirm an endocrine diagnosis.
A mildly high LH-to-FSH ratio is neither necessary nor sufficient for PCOS. The ratio varies across the cycle, is altered by contraception, and becomes less useful after age 35. If a report includes it, treat it as supporting context rather than a verdict; our cortisol versus ACTH guide shows the same principle in another hormone axis.
Why free testosterone calculations can disagree
Free testosterone can be measured directly or estimated from total testosterone, SHBG, and albumin; methods are not interchangeable. When the result could alter imaging or treatment, clinicians often favour a high-quality total testosterone method plus SHBG over a lone direct free-testosterone immunoassay.
Pregnancy, Perimenopause and Life-Stage Context for DHEA-S
DHEA-S normally declines with age, so the same value has different meaning at 25 and 55. A DHEA-S level of 300 µg/dL may be unremarkable in a woman in her twenties but clearly above range after menopause, depending on the laboratory method.
Adrenal androgen production peaks in early adulthood and falls progressively thereafter, a process sometimes called adrenopause. That decline is why laboratories publish decade-specific intervals, although the exact curves differ by assay. A postmenopausal woman with new hirsutism, high DHEA-S, or rising testosterone should have a more deliberate evaluation than someone with stable symptoms since her twenties.
Pregnancy creates a specialised endocrine environment in which maternal DHEA-S is metabolised by the placenta, and reference ranges are not interchangeable with non-pregnant ranges. Obstetric and endocrine teams should interpret unexpected results together, especially if there is maternal virilisation. Home hormone panels are not a safe substitute for pregnancy-specific clinical assessment.
Perimenopause can produce irregular cycles that resemble PCOS, while declining ovarian oestrogen may reveal facial hair that was previously less visible. Before starting menopausal hormone therapy, establish a baseline where clinically indicated; the pre-HRT blood-test checklist can help frame questions for a clinician.
The postmenopausal red flag
New virilisation after menopause is never explained by "normal ageing" until significant androgen excess has been excluded. The urgency rises when the change is measurable over months rather than a slow, stable increase in a few coarse hairs over years.
A Practical Next-Step Plan After High DHEA-S
For a mild, unexpected high DHEA-S without rapid symptoms, arrange a routine appointment, review supplements, and repeat a standardised panel. For marked elevation or virilisation, ask for an expedited endocrine or gynaecology assessment and bring the original report rather than relying on memory.
Start with a one-page timeline: first symptoms, cycle dates, pregnancy possibility, body-hair or acne changes, weight change, medicines, supplements, and previous androgen results. Include whether a close contact uses testosterone gel. A clinician can often identify the most informative next test from this timeline faster than from a broad, untimed laboratory panel.
Ask three focused questions: Is the result DHEA or DHEA-S? Does the magnitude fit my age-specific range? Which companion result would change management? This approach makes appointments more productive and avoids the common trap of ordering every hormone repeatedly. You can create a concise lääkärikäynnin laboratoriokooste before the consultation.
Do not self-treat with spearmint, inositol, adrenal products, or anti-androgen supplements as a substitute for establishing the cause. Some may be reasonable in a diagnosed context, but they can complicate interpretation and pregnancy planning. Treatment follows the diagnosis: stopping DHEA exposure, addressing PCOS risk, glucocorticoid management for confirmed non-classic CAH, or specialist care for rare sources.
How quickly should follow-up happen
A value just above range with no progressive symptoms can usually be reviewed within several weeks. A result above 700 µg/dL, testosterone above 150-200 ng/dL, or rapid virilisation merits contact within days, not months.
What Not to Do When DHEA Is High
Do not assume high DHEA proves chronic stress, PCOS, infertility, or an adrenal tumour. The most harmful response is often treating a lab flag before confirming the analyte, result, exposure history, and clinical pattern.
Avoid purchasing "hormone balancing" blends to lower DHEA. Products containing licorice, pregnenolone, DHEA, testosterone precursors, or undisclosed steroid-like compounds can change blood pressure, potassium, menstrual cycles, and laboratory interpretation. A natural label does not establish dose accuracy or safety.
Do not interpret a normal cortisol, pelvic ultrasound, or normal period as proof that a high DHEA-S needs no follow-up. Each test has a narrow purpose. The better approach is serial, comparable results and symptoms over time; our longitudinal test analysis guide explains how to identify a meaningful trend.
Equally, do not panic over one small deviation. Laboratory reference intervals include 95% of a reference population, so about 1 in 20 healthy people will fall outside one limit by chance. When multiple results are ordered, incidental flags become more likely, which is why an experienced pattern review is more useful than internet searching each marker separately.
Hair removal does not invalidate the assessment
Waxing, shaving, laser treatment, and cosmetic camouflage are personal choices and do not prevent a clinician from evaluating androgen excess. What matters is the pace of change, areas affected, and whether other virilising features have appeared.
Can Diet or Lifestyle Lower High DHEA?
Diet and lifestyle do not directly treat a marked DHEA-S elevation or rule out adrenal disease. In women with PCOS or insulin resistance, however, gradual weight reduction, sleep regularity, and physical activity can improve ovulation and free-testosterone exposure even if DHEA-S changes little.
A realistic target of 150 minuuttia viikossa of moderate activity plus resistance work on 2 days can improve insulin sensitivity and cardiometabolic risk. If body-weight reduction is appropriate, a 5-10% loss may improve cycle regularity in PCOS, though it is not a requirement for care and does not prove that DHEA-S was lifestyle-driven. Choose support that respects fertility goals and eating-disorder history.
There is no proven food that reliably "flushes" DHEA from the body. Adequate protein, fibre-rich plants, unsaturated fats, and regular meals can support metabolic health, but restrictive detox diets often worsen fatigue and obscure the clinical picture. If you use supplements for training or menopause, review their ingredients before repeat testing; our lisämunuaislisän turvallisuusopas explains common concerns.
Sleep loss and stress can worsen acne, appetite, glucose regulation, and the experience of symptoms, yet they should not be used to explain away virilisation or a DHEA-S of 800 µg/dL. I tell patients that supportive habits are worthwhile alongside investigation, not instead of it. That distinction prevents both false reassurance and unnecessary guilt.
A note on inositol
Myo-inositol may help some people with PCOS-related ovulatory dysfunction, but evidence does not establish it as a treatment for unexplained high DHEA-S. Discuss dose, fertility plans, and glucose-lowering medicines with a clinician before starting it.
Using an AI Result Explanation Safely Alongside Clinical Care
AI can organise a high DHEA report, identify unit mismatches, and flag combinations that merit timely follow-up, but it cannot examine for virilisation or decide whether imaging is appropriate. Use AI interpretation to prepare better questions, then confirm decisions with a qualified clinician who has your full history.
Kantesti AI interprets DHEA and DHEA-S results by checking age-specific reference intervals, units, companion hormone values, and changes across previous reports. Kantesti is an AI biomarker interpretation platform designed to turn a laboratory PDF or photograph into a structured explanation in about 60 seconds, while preserving the distinction between education and diagnosis. It is especially useful when one report uses µg/dL and another uses µmol/L.
Our clinical team reviews medical content against established laboratory and endocrine standards, and the lääketieteellistä validointikatsausta describes how interpretation quality and safety boundaries are approached. Kantesti does not diagnose PCOS, congenital adrenal hyperplasia, or an adrenal growth from one hormone result; those diagnoses require clinical assessment, targeted testing, and sometimes imaging.
If your interpretation identifies a marked result or urgent symptom cluster, share the original report with your clinician promptly. The Lääketieteellinen neuvoa-antava toimikunta supports the clinical oversight behind our educational materials, but an online explanation should never delay urgent evaluation. Bottom line: confirm the test, remove avoidable exposures, assess the pattern, and escalate quickly when the changes are rapid or marked.
Usein kysytyt kysymykset
What level of DHEA-S is too high in a woman?
A DHEA-S level above the laboratory's age-specific upper limit is high, but the degree matters more than the flag alone. Many laboratories use upper limits of roughly 320-430 µg/dL in women aged 18-29 and lower limits with age. A DHEA-S concentration above about 700 µg/dL warrants prompt assessment for an adrenal androgen-producing source, particularly when facial hair, acne, voice change, or scalp hair loss is advancing quickly. The reporting laboratory's own range and units remain the starting point because methods differ.
Voiko PCOS aiheuttaa korkean DHEA-S:n?
PCOS can cause a mild-to-moderate high DHEA-S result, but it more commonly raises testosterone, free testosterone, or androstenedione. DHEA-S near or above 700 µg/dL is not typical for routine PCOS and should prompt clinicians to consider adrenal causes, supplement exposure, and non-classic congenital adrenal hyperplasia. PCOS diagnosis requires a pattern of ovulatory dysfunction and hyperandrogenism after relevant alternatives have been excluded. A single DHEA-S result cannot diagnose PCOS.
Can stress cause high DHEA in women?
Acute stress, sleep disruption, illness, and collection timing can contribute to variation in DHEA, which has a short half-life of roughly 15-30 minutes. They are less convincing explanations for a persistently marked DHEA-S elevation because DHEA-S is a more stable adrenal marker with a half-life of about 7-10 hours. Stress should not be used to dismiss rapid virilisation or DHEA-S above 700 µg/dL. Repeat testing under standardised conditions helps separate biologic variation from a sustained result.
Should I stop taking DHEA before a blood test?
Non-prescribed DHEA should generally be stopped before repeat testing after discussing the timing with the ordering clinician, because doses of 25-50 mg daily can substantially raise DHEA and DHEA-S. Keep the supplement bottle or a photograph of the label because dose and ingredients are clinically useful. Do not abruptly stop prescribed glucocorticoids or other prescription hormones without medical advice. Document the final dose date so the repeat result can be interpreted correctly.
What tests are done after high DHEA-S?
Common follow-up tests include repeat DHEA-S, total testosterone measured by LC-MS/MS when available, SHBG, early-morning 17-hydroxyprogesterone, prolactin, TSH, and pregnancy testing when relevant. An 8 a.m. follicular-phase 17-hydroxyprogesterone above 200 ng/dL often leads to ACTH stimulation testing for non-classic congenital adrenal hyperplasia. Cortisol testing is selected when symptoms suggest cortisol excess, and imaging is usually reserved for confirmed marked elevations or rapid virilisation. The exact panel depends on age, symptoms, medicines, and whether DHEA or DHEA-S was elevated.
Does high DHEA-S mean an adrenal tumour?
High DHEA-S does not automatically mean an adrenal tumour; supplements, non-classic congenital adrenal hyperplasia, and PCOS-associated adrenal androgen excess are more frequent explanations for smaller elevations. The concern rises with DHEA-S above about 700 µg/dL, a rapidly increasing result, or virilising changes over 3-12 months. Clinicians usually confirm the result and assess testosterone, 17-hydroxyprogesterone, cortisol-related features, and medication exposure before ordering targeted imaging. Prompt evaluation is sensible, but most abnormal results do not prove cancer.
Hanki tekoälypohjainen verikoeanalyysi tänään
Liity yli 2 miljoonan käyttäjän joukkoon maailmanlaajuisesti, jotka luottavat Kantesti:hen saadakseen välittömän ja tarkan laboratoriotestianalyysin. Lataa verikoetuloksesi ja saat kattavan tulkinnan 15,000+-biomarkkereista sekunneissa.
📚 Viitatut tutkimusjulkaisut
Klein, T., Mitchell, S., & Weber, H. (2026). Rautatutkimusopas: TIBC, raudan kylläisyys ja sitoutumiskyky. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). aPTT:n normaali alue: D-dimeerin ja proteiini C:n veren hyytymisopas. Kantesti AI Medical Research.
📖 Ulkoiset lääketieteelliset lähteet
Martin KA ym. (2018). Hirsutismin arviointi ja hoito premenopausaalisilla naisilla: Endokrinologiyhdistyksen (Endocrine Society) kliininen käytännön ohje. Journal of Clinical Endocrinology & Metabolism.
Speiser PW ym. (2018). Synnynnäinen lisämunuaisen liikakasvu (CAH) steroidin 21-hydroksylaasin puutoksen vuoksi: Endokrinologiyhdistyksen (Endocrine Society) kliininen käytännön ohje. Journal of Clinical Endocrinology & Metabolism.
Azziz R et al. (2009). The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Journal of Clinical Endocrinology & Metabolism.
📖 Jatka lukemista
Tutustu lisää asiantuntijoiden arvioimiin lääketieteellisiin oppaisiin Kantesti lääketieteelliseltä tiimiltämme:

Alhainen kuparipitoisuus: Syyt, oireet, laboratoriolöydökset ja seuraavat askeleet
Mineraaliterveyden laboratoriotulkinnan 2026 päivitys Potilasystävällinen Matala kuparitulos on yleensä vihje etsiä...
Lue artikkeli →
Korkean suoran bilirubiinin merkitys: Tukos vai hepatiitti?
Maksaterveyden laboratoriotulkinta 2026 Päivitys Potilasystävällinen Korkea suoran bilirubiinin tulos tarkoittaa, että maksalla on konjugoitunut bilirubiini...
Lue artikkeli →
Mitä korkea LH tarkoittaa? Ovulaatio, vaihdevuodet ja aivolisäkkeen vihjeet
Hormoniterveyden laboratorioanalyysi 2026 Päivitys Potilasystävällinen Korkea luteinisoiva hormonin (LH) taso voi olla normaali ovulaatiosignaali,...
Lue artikkeli →
Mitä matala vapaa T4 tarkoittaa normaalilla TSH:lla
Kilpirauhasen terveyden laboratoriotulkinta 2026 Päivitys Potilasystävällinen Matala vapaa T4 ja TSH laboratorioskaalan sisällä...
Lue artikkeli →
Mitä korkea MCHC tarkoittaa? Syyt, artefaktit ja vihjeet
CBC-tulkinta Hematologia 2026 Päivitys Potilasystävällinen Korkea MCHC on harvinainen ja usein hyödyllisempi vihjeenä...
Lue artikkeli →
Laktaattitestin tulokset: kiristysside- ja ajoitusvirheet
Hätätilanteen biomarkkerilaboratorion tulkinta 2026 päivitys Potilasystävällinen Odottamaton laktaattitulos voi heijastaa todellista verenkierto- tai metabolista...
Lue artikkeli →Tutustu kaikkiin terveysoppaisiimme ja tekoälypohjaisiin verikoetulosten analysointityökaluihin osoitteessa kantesti.net
⚕️ Lääketieteellinen vastuuvapauslauseke
Tämä artikkeli on tarkoitettu vain koulutustarkoituksiin eikä se muodosta lääketieteellistä neuvontaa. Ota aina yhteyttä pätevään terveydenhuollon ammattilaiseen diagnoosi- ja hoitopäätöksiä varten.
E-E-A-T-luottamussignaalit
Kokea
Lääkärin johtama kliininen arviointi laboratoriotulkinnan työnkuluista.
Asiantuntemus
Laboratoriolääketiede keskittyy siihen, miten biomarkkerit käyttäytyvät kliinisessä kontekstissa.
Auktoriteetti
Kirjoittanut tohtori Thomas Klein, tarkistanut tohtori Sarah Mitchell ja professori tohtori Hans Weber.
Luotettavuus
Näyttöön perustuva tulkinta selkeillä jatkopoluilla, jotka vähentävät hälytystä.